» Articles » PMID: 23288151

Dynamin-related Protein-1 Controls Fusion Pore Dynamics During Platelet Granule Exocytosis

Overview
Date 2013 Jan 5
PMID 23288151
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Platelet granule exocytosis serves a central role in hemostasis and thrombosis. Recently, single-cell amperometry has shown that platelet membrane fusion during granule exocytosis results in the formation of a fusion pore that subsequently expands to enable the extrusion of granule contents. However, the molecular mechanisms that control platelet fusion pore expansion and collapse are not known.

Methods And Results: We identified dynamin-related protein-1 (Drp1) in platelets and found that an inhibitor of Drp1, mdivi-1, blocked exocytosis of both platelet dense and α-granules. We used single-cell amperometry to monitor serotonin release from individual dense granules and, thereby, measured the effect of Drp1 inhibition on fusion pore dynamics. Inhibition of Drp1 increased spike width and decreased prespike foot events, indicating that Drp1 influences fusion pore formation and expansion. Platelet-mediated thrombus formation in vivo after laser-induced injury of mouse cremaster arterioles was impaired after infusion of mdivi-1.

Conclusions: These results demonstrate that inhibition of Drp1 disrupts platelet fusion pore dynamics and indicate that Drp1 can be targeted to control thrombus formation in vivo.

Citing Articles

Platelets and mitochondria: the calcium connection.

Shehwar D, Barki S, Aliotta A, Calderara D, Veuthey L, Portela C Mol Biol Rep. 2025; 52(1):276.

PMID: 40029418 DOI: 10.1007/s11033-025-10389-3.


The fate of mitochondria during platelet activation.

Grichine A, Jacob S, Eckly A, Villaret J, Joubert C, Appaix F Blood Adv. 2023; 7(20):6290-6302.

PMID: 37624769 PMC: 10589785. DOI: 10.1182/bloodadvances.2023010423.


Sulfenylation links oxidative stress to protein disulfide isomerase oxidase activity and thrombus formation.

Yang M, Chiu J, Scartelli C, Ponzar N, Patel S, Patel A J Thromb Haemost. 2023; 21(8):2137-2150.

PMID: 37037379 PMC: 10657653. DOI: 10.1016/j.jtha.2023.03.034.


Is autologous platelet activation the key step in ovarian therapy for fertility recovery and menopause reversal?.

Rickers N, Scott Sills E Biomedicine (Taipei). 2023; 12(4):1-8.

PMID: 36816178 PMC: 9910228. DOI: 10.37796/2211-8039.1380.


Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems.

Nunn A, Guy G, Brysch W, Bell J Biomedicines. 2022; 10(12).

PMID: 36551869 PMC: 9775339. DOI: 10.3390/biomedicines10123113.


References
1.
Cui M, Tang X, Christian W, Yoon Y, Tieu K . Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem. 2010; 285(15):11740-52. PMC: 2857048. DOI: 10.1074/jbc.M109.066662. View

2.
Graham G, Ren Q, Dilks J, Blair P, Whiteheart S, Flaumenhaft R . Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo. Blood. 2009; 114(5):1083-90. PMC: 2721786. DOI: 10.1182/blood-2009-03-210211. View

3.
Ye Y, Perez-Polo J, Birnbaum Y . Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions. Ann N Y Acad Sci. 2010; 1207:76-82. DOI: 10.1111/j.1749-6632.2010.05725.x. View

4.
Smirnova E, Shurland D, Ryazantsev S, van der Bliek A . A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol. 1998; 143(2):351-8. PMC: 2132828. DOI: 10.1083/jcb.143.2.351. View

5.
Jasuja R, Passam F, Kennedy D, Kim S, van Hessem L, Lin L . Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest. 2012; 122(6):2104-13. PMC: 3366406. DOI: 10.1172/JCI61228. View